IRAK4-IN-6 is an orally efficacious and selective IRAK4 inhibitor with an IC50 of 4 nM, and targetes MyD88 L265P mutant diffuse large B cell lymphoma[1].
Molecular Weight:
504.59
Purity:
99.30
CAS Number:
[2454244-02-9]
Formula:
C25H32N10O2
Target:
IRAK
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted